Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy's Labs to file its reply to the injunction petition moved by Danish drug maker Novo Nordisk for its blockbuster weight-loss drug semaglutide, which is sold under the brand name Wegovy.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
You may also like
Conversion racket: Six linked to Chhangur Baba held in Uttarakhand; aide's properties demolished
Barcelona 'hostile city' for visitors as tourist tax doubles to 15 Euros a night
BBC Morning Live Doctor Punam issues health warning after coffee shop fainting
Lando Norris stars in Belgian GP qualifying as Lewis Hamilton suffers latest F1 nightmare
Coronation Street's Jack P Shepherd kisses bride in first wedding photos
